239 related articles for article (PubMed ID: 4677376)
1. [Assay methods and significance of fibrin-fibrinogen degradation products in blood].
Shinada S
Nihon Ketsueki Gakkai Zasshi; 1972 Oct; 35(5):607-16. PubMed ID: 4677376
[No Abstract] [Full Text] [Related]
2. [Detection of fibrinogen and fibrin degradation products (FDP) and its clinical significance].
Fujimaki M; Ikematsu S; Takeuchi I
Nihon Rinsho; 1973 Apr; 31(4):798-804. PubMed ID: 4580396
[No Abstract] [Full Text] [Related]
3. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.
Hawiger J; Niewiarowski S; Gurewich V; Thomas DP
J Lab Clin Med; 1970 Jan; 75(1):93-108. PubMed ID: 4243578
[No Abstract] [Full Text] [Related]
4. Fibrinogen break-down products and clotting parameters.
Gormsen J; Laursen B
Thromb Diath Haemorrh; 1967 May; 17(3-4):467-81. PubMed ID: 4231951
[No Abstract] [Full Text] [Related]
5. The tanned red cell hemagglutination-inhibition immunoassay of fibrinogen-fibrin degradation products. Methodological and statistical aspects.
Hahn L
Thromb Res; 1974 Mar; 4(3):417-36. PubMed ID: 4857332
[No Abstract] [Full Text] [Related]
6. Detection of fibrinogen-fibrin degradation products by counterelectrophoresis.
Brody JI
J Clin Pathol; 1972 Sep; 25(9):754-6. PubMed ID: 5086217
[TBL] [Abstract][Full Text] [Related]
7. Exploration of intraglomerular phenomena by measurement of the level of fibrin degradation products in the renal vein blood.
Conte J; Boneu B; Mignon-Conte ; Suc JM
Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):915-26. PubMed ID: 4807811
[No Abstract] [Full Text] [Related]
8. Comparison of ethanol and protamine tests in demonstration of soluble fibrin and early products of fibrin degradation.
Konttinen YP; Kemppainen L; Turunen O
Thromb Diath Haemorrh; 1972 Dec; 28(3):342-50. PubMed ID: 4675265
[No Abstract] [Full Text] [Related]
9. A comparative study of adult and fetal sheep fibrinogen, sulf-fibrinogen and fibrinogen degradation products.
Loly W; Israels LG; Bishop AJ; Israels ED
Thromb Diath Haemorrh; 1971 Dec; 26(3):526-40. PubMed ID: 4259443
[No Abstract] [Full Text] [Related]
10. [Determination of FDP by staphylococcal clumping test and the significance of the method in consumption coagulopathy].
Yamada K; Yamada Z; Nakazawa S; Matsuoka S
Rinsho Ketsueki; 1972 Jun; 13(3):411-4. PubMed ID: 4674971
[No Abstract] [Full Text] [Related]
11. [Evaluation of staphylococcal clumping test and its clinical application].
Nakazawa S; Meguro T; Yamada Z; Yamada K
Rinsho Ketsueki; 1972 Jun; 13(3):363-9. PubMed ID: 4674966
[No Abstract] [Full Text] [Related]
12. The structure of the fibrinogen degradation products.
Marder VJ; Budzynski AZ
Prog Hemost Thromb; 1974; 2(0):141-74. PubMed ID: 4137300
[No Abstract] [Full Text] [Related]
13. Plasmin lysis of fibrinogen and fibrin and the antigenic properties of their degradation products.
Ekert H; Muntz RH
Br J Haematol; 1972 Jan; 22(1):103-10. PubMed ID: 4258329
[No Abstract] [Full Text] [Related]
14. [Reliability of tests for fibrinogen (fibrin) degradation products in plasma with thrombin coagulase, reptilase and thrombin clotting time (author's transl)].
Wenzel E; Holzhüter H; Muschietti F; Angelkort B; Ochs HG; Pusztai-Markos S; Nowak H; Stürner H
Dtsch Med Wochenschr; 1974 Apr; 99(15):746-56. PubMed ID: 4858105
[No Abstract] [Full Text] [Related]
15. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
Colick JA; Fisher LM
Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
[No Abstract] [Full Text] [Related]
16. [Reliability of reptilase and thrombin coagulase coagulation times for measurement of antithrombin VI activity with reference to immunoelectrophoretic characteristics of various fibrinogen and fibrin fission products].
Stürner KH; Holzhüter H; Ochs HG; Angelkort B; Muchietti F; Wenzel E
Verh Dtsch Ges Inn Med; 1973; 79():1328-30. PubMed ID: 4790173
[No Abstract] [Full Text] [Related]
17. Characterization and significance of urinary fibrin degradation products.
Cortes P; Potter EV; Kwaan HC
J Lab Clin Med; 1973 Sep; 82(3):377-89. PubMed ID: 4199524
[No Abstract] [Full Text] [Related]
18. [Measurement of fibrinogen degradation products: its usefulness in consumption coagulopathies].
Thuot C; Perron L
Union Med Can; 1973 Jan; 102(1):66-9. PubMed ID: 4706340
[No Abstract] [Full Text] [Related]
19. [Serological characteristics of fibrin degradation products in human fluid plasma].
Miura Y; Yasuda J; Abe H
Rinsho Byori; 1971 Aug; 19():Suppl:257. PubMed ID: 5167953
[No Abstract] [Full Text] [Related]
20. [Methods of determination of fibrin fibrinogen degradation products (review of the literature)].
Guseínov ChS; Prozorovskaia NN; Mikhaĭlova ND; Gorelova AM; Lagutina NIa
Lab Delo; 1978; (5):259-66. PubMed ID: 79007
[No Abstract] [Full Text] [Related]
[Next] [New Search]
